Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-25T02:01:40.331Z Has data issue: false hasContentIssue false
  • English
  • Français

Neurotic and Thyrotoxic Anxiety: Clinical, Psychological and Physiological Measurements

Published online by Cambridge University Press:  29 January 2018

Steven Greer ,
Ian Ramsay  and
Christopher Bagley
Steven Greer
Affiliation:
Department of Psychological Medicine and Medical Unit, King's College Hospital, London, S.E.5
Ian Ramsay
Affiliation:
Department of Medicine, King's College Hospital Medical School, London, S.E.5; now Consultant Physician, Regional Endocrine Centre, North Middlesex Hospital, London, N.18
Christopher Bagley
Affiliation:
Centre for Social Research, University of Sussex, Falmer, Brighton
Get access Rights & Permissions [Opens in a new window]

Extract

Among the various methods of assessing morbid anxiety the psychiatric interview remains pre-eminent. By this means, we attempt to elicit what patients actually feel—the criterion against which all other measurements are validated. Dissatisfaction with the subjective nature of psychiatric interviews and with their low reliability (Cattell and Scheier, 1958; Kreitman, Sainsbury, Morrissey, Towers, and Scrivener, 1961) has led, on the one hand, to the use of rating scales which quantify subjective clinical judgements (Kellner, Kelly and Sheffield, 1968), and, on the other, to the development of techniques which purport to measure anxiety objectively. The latter fall into two broad categories: (i) questionnaires such as the Manifest Anxiety Scale (Taylor, 1953) and the IPAT Anxiety Scale (Cattell and Scheier, 1963), and (ii) measurements of somatic correlates of anxiety, in particular the various endocrine and physiological responses reviewed by Mason (1968) and Lader (1969), respectively.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 122 , Issue 570 , May 1973 , pp. 549 - 554
Copyright
Copyright © Royal College of Psychiatrists, 1973 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Black, A. A. (1966). ‘Factors predisposing to a placebo response in new out patients with anxiety states.’ British Journal of Psychiatry, 112, 557–67.CrossRefGoogle ScholarPubMed
Cattell, R. B., and Scheier, I. H. (1958). ‘Clinical validities by analyzing the psychiatrist exemplified in relation to anxiety diagnoses.’ American Journal of Orthopsychiatry, 28, 699–713.CrossRefGoogle Scholar
Cattell, R. B., and Scheier, I. H. (1963). IP AT Anxiety Scale Questionnaire. Champaign: Illinois.Google Scholar
Hampshire, S. (1972). Freedom of Mind. Oxford.Google Scholar
Kellner, R., Kelly, A. V., and Sheffield, B. F. (1968). ‘The assessment of changes in anxiety in a drug trial: a comparison of methods.’ British Journal of Psychiatry, 114, 863–9.CrossRefGoogle Scholar
Kellner, R., Kelly, A. V., and Sheffield, B. F. (1972). ‘Improvement criteria in drug trials with neurotic patients.’ Part 2. Psychological Medicine, 2, 73–80.CrossRefGoogle Scholar
Kreitman, N., Sainsbury, P., Morrissey, J., Towers, J., and Scrivener, J. (1960). ‘The reliability of psychiatric assessment: an analysis.’ Journal of Mental Science, 107, 887–908.CrossRefGoogle Scholar
Lader, M. H., and Wing, L. (1966). Physiological Measures, Sedative Drugs and Morbid Anxiety. Maudsley Monograph No. 14, London.Google Scholar
Lader, M. H., and Wing, L. (1969). ‘Psychophysiology of anxiety’, in Studies of Anxiety (ed. Lader, ). British Journal of Psychiatry Special Publication No. 3.Google Scholar
Lader, M. H., and Wing, L. (1971). ‘Physiological measures in psychiatry’, in The Scientific Basis of Medicine Annual Renews (ed. Gilliland, and Francis, ). London.Google Scholar
Martin, I. (1960). ‘Somatic reactivity’, in Handbook of Abnormal Psychology (ed. Eysenck, ). London.Google Scholar
Mason, J. W. (1968). ‘Organisation of psychoendocrine mechanisms.’ Psychosomatic Medicine. 30(5), 576–607 and 666–81.Google Scholar
Ramsay, I., Greer, S., and Bagley, C. (1973). ‘Propranolol in neurotic and thyrotoxic anxiety.’ Brit. J. Psychiat., 00.Google Scholar
Robinson, J. T., Davies, L. S., Kreitman, N., and Knowles, J. B. (1965). ‘A double-blind trial of oxypertine for anxiety neurosis.’ British Journal of Psychiatry, 111, 527–9.CrossRefGoogle Scholar
Sternbach, R. A. (1960). ‘Some relationships among various ‘dimensions’ of autonomic activity.’ Psychosomatic Medicine, 22, 430–4.CrossRefGoogle Scholar
Taylor, J. A. (1953). ‘A personality scale of manifest anxiety.’ Journal of Abnormal and Social Psychology, 48, 285–90.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.